Package
Latest Janssen Pharmaceutica NV Patents:
- Radiolabelled MGL PET ligands
- Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one
- Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
- Compositions containing ibrutinib
- Processes and intermediates for preparing a Btk inhibitor
In the drawings, the broken lines are for the purpose of illustrating portions of the package that form no part of the claimed design.
Claims
The ornamental design for a package, as shown and described.
D430015 | August 29, 2000 | Himbert |
6228324 | May 8, 2001 | Hasegawa et al. |
D549094 | August 21, 2007 | Oner et al. |
D569721 | May 27, 2008 | Gedanke |
D623935 | September 21, 2010 | Kim et al. |
D697398 | January 14, 2014 | Guevara-ludt |
D743249 | November 17, 2015 | Wintmolders et al. |
D750502 | March 1, 2016 | Kirchmayr et al. |
D754547 | April 26, 2016 | Psimadas et al. |
D758180 | June 7, 2016 | Wintmolders et al. |
9422094 | August 23, 2016 | Niiro et al. |
D765520 | September 6, 2016 | Gunder et al. |
D767985 | October 4, 2016 | Schouten |
D774903 | December 27, 2016 | Joergensen et al. |
D775945 | January 10, 2017 | Dichiara et al. |
D780599 | March 7, 2017 | Tilahun et al. |
D785451 | May 2, 2017 | Biery |
D788936 | June 6, 2017 | Schill |
D790987 | July 4, 2017 | Damon et al. |
D790988 | July 4, 2017 | Vasiliadis et al. |
D804962 | December 12, 2017 | Fox et al. |
D808823 | January 30, 2018 | Greene et al. |
D810556 | February 20, 2018 | Holm |
D814314 | April 3, 2018 | Mecker et al. |
D814918 | April 10, 2018 | Bos |
D818815 | May 29, 2018 | Psimadas et al. |
10053272 | August 21, 2018 | Doherty et al. |
D840800 | February 19, 2019 | Farrell |
D841460 | February 26, 2019 | Toledo |
D842092 | March 5, 2019 | Toledo |
D847253 | April 30, 2019 | Chang |
D847624 | May 7, 2019 | Farrell |
D850289 | June 4, 2019 | Mccay et al. |
D853249 | July 9, 2019 | Mckendree |
D854408 | July 23, 2019 | Farrell |
D855450 | August 6, 2019 | Klein et al. |
D856793 | August 20, 2019 | Debnath et al. |
D860435 | September 17, 2019 | Wang |
D870550 | December 24, 2019 | Klein et al. |
D871205 | December 31, 2019 | Farrell |
D873131 | January 21, 2020 | Watanabe |
D877613 | March 10, 2020 | Mcfaul et al. |
10577165 | March 3, 2020 | Sadowski et al. |
D882415 | April 28, 2020 | Duarte De Castro et al. |
D887283 | June 16, 2020 | Sennett et al. |
D887700 | June 23, 2020 | Folger et al. |
D890330 | July 14, 2020 | Wang |
D892636 | August 11, 2020 | Troudt et al. |
D898588 | October 13, 2020 | An et al. |
D906102 | December 29, 2020 | Cook et al. |
D909890 | February 9, 2021 | Bryzek et al. |
D915904 | April 13, 2021 | Duarte De Castro et al. |
D918710 | May 11, 2021 | Hampton et al. |
D920573 | May 25, 2021 | Scudieri |
D934069 | October 26, 2021 | Cook |
D938831 | December 21, 2021 | Picken et al. |
D939139 | December 21, 2021 | Waters |
11230419 | January 25, 2022 | Tilahun |
D945847 | March 15, 2022 | Chen |
D949018 | April 19, 2022 | Gysel et al. |
D953886 | June 7, 2022 | Collier et al. |
D957245 | July 12, 2022 | Müller |
D958645 | July 26, 2022 | Debnath et al. |
D959052 | July 26, 2022 | Gerhards et al. |
D961376 | August 23, 2022 | Cook |
D964171 | September 20, 2022 | Gysel |
D985384 | May 9, 2023 | Cannamela |
20180085515 | March 29, 2018 | Mide |
20230037529 | February 9, 2023 | Cannamela |
113226 | February 1992 | AU |
316236 | September 2007 | AU |
316320 | September 2007 | AU |
201713235 | June 2017 | AU |
2015001855 | December 2014 | CL |
2017001388 | January 2016 | CL |
2020001658 | December 2019 | CL |
2020001659 | December 2019 | CL |
2020001661 | December 2019 | CL |
2020001660 | October 2020 | CL |
09046884 | May 2011 | CO |
0002438940001 | January 2005 | EM |
20200007409 | December 2019 | NC |
D139069 | February 2011 | TW |
D171654 | November 2015 | TW |
- Dispositivo de medicamento Spravato (Janssen Pharmaceutica NV) Mar. 6, 2019, www.scmp., 2 pages.
Type: Grant
Filed: Mar 9, 2023
Date of Patent: Feb 20, 2024
Assignee: Janssen Pharmaceutica NV (Beerse)
Inventors: Michael Cannamela (Atlantic Highland, NJ), Emma Hubert (San Jose, CA)
Primary Examiner: Rhea Shields
Application Number: 29/872,262